21![Press Release, GILUPI participates in European consortium to validate blood-based biomarkers for cancer Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free tumor DNA (cfDNA) and mi Press Release, GILUPI participates in European consortium to validate blood-based biomarkers for cancer Blood-based biomarkers such as circulating tumor cells (CTCs), circulating free tumor DNA (cfDNA) and mi](https://www.pdfsearch.io/img/3811527858f351e20327c618f0ca34cd.jpg) | Add to Reading ListSource URL: www.gilupi.deLanguage: English - Date: 2015-04-20 09:14:39
|
---|
22![F-star Announces Initiation of a Phase 1 Clinical Trial for FS102 for the Treatment of HER2-Positive Breast and Gastric Cancer CAMBRIDGE, UK – 9 JanuaryF-star, a biopharmaceutical company focused on oncology and F-star Announces Initiation of a Phase 1 Clinical Trial for FS102 for the Treatment of HER2-Positive Breast and Gastric Cancer CAMBRIDGE, UK – 9 JanuaryF-star, a biopharmaceutical company focused on oncology and](https://www.pdfsearch.io/img/d6e209649cc6056b6db7d305dd653e8b.jpg) | Add to Reading ListSource URL: www.f-star.comLanguage: English - Date: 2015-01-09 11:56:08
|
---|
23![Clinical Chemistry 57:3 421–Cancer Diagnostics Molecular Characterization of Circulating Tumor Cells in Clinical Chemistry 57:3 421–Cancer Diagnostics Molecular Characterization of Circulating Tumor Cells in](https://www.pdfsearch.io/img/2c4f66556408853a72ed80326153d118.jpg) | Add to Reading ListSource URL: en.actc-lab.chem.uoa.grLanguage: English - Date: 2012-03-25 13:28:50
|
---|
24![ESA Patentverwertungsagentur Sachsen-Anhalt GmbH Technology Offer Novel enzyme inhibitors for the treatment of aggressive forms of breast cancer ESA Patentverwertungsagentur Sachsen-Anhalt GmbH Technology Offer Novel enzyme inhibitors for the treatment of aggressive forms of breast cancer](https://www.pdfsearch.io/img/7a9fff382913c0c610509a987b0ec0e8.jpg) | Add to Reading ListSource URL: www.esa-pva.deLanguage: English - Date: 2014-09-18 05:29:30
|
---|
25![Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy (NEW YORK and CAMBRIDGE, UK – October 28, Bristol-Myers Squibb Compa Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy (NEW YORK and CAMBRIDGE, UK – October 28, Bristol-Myers Squibb Compa](https://www.pdfsearch.io/img/73bdf786590e37f08ea1116a7642ec4d.jpg) | Add to Reading ListSource URL: www.f-star.comLanguage: English - Date: 2014-10-28 07:38:04
|
---|
26![Best Practice Standards for EGFR Testing in Colorectal Cancer in Canada Banerjee D, Guha AK, Guindi MM, Haliotis T, Hanna W, Jass JR, Jothy S, Kanthan R, O’Malley F, Srigley J, Têtu B, Wightman R, Dranitsaris G, for t Best Practice Standards for EGFR Testing in Colorectal Cancer in Canada Banerjee D, Guha AK, Guindi MM, Haliotis T, Hanna W, Jass JR, Jothy S, Kanthan R, O’Malley F, Srigley J, Têtu B, Wightman R, Dranitsaris G, for t](https://www.pdfsearch.io/img/e1a76f23a1a43b3b2bc711649827706a.jpg) | Add to Reading ListSource URL: www.cap-acp.orgLanguage: English - Date: 2014-10-05 16:11:00
|
---|
27![Testing Gap Report: Exposing the variations in biomarker testing in bowel, breast and lung cancers Date of preparation: January 2015 Job number: ERB14-0242 Testing Gap Report: Exposing the variations in biomarker testing in bowel, breast and lung cancers Date of preparation: January 2015 Job number: ERB14-0242](https://www.pdfsearch.io/img/788885ea58ea2ca9c8a1af48fa3f1b9a.jpg) | Add to Reading ListSource URL: www.bowelcanceruk.org.ukLanguage: English - Date: 2015-03-03 10:37:42
|
---|
28![Legend Open to Accrual Pending Accrual on Hold Advanced Breast Cancer Legend Open to Accrual Pending Accrual on Hold Advanced Breast Cancer](https://www.pdfsearch.io/img/d80b50351e3438e37683ceaee9ddc12d.jpg) | Add to Reading ListSource URL: cancer.ucsf.eduLanguage: English - Date: 2014-10-06 14:59:53
|
---|
29![Embargoed For Release: 8:30 a.m. ET, April 20, 2015 To interview Philip Rosenberg, contact the NCI press office at orFor a photo of Rosenberg, click here. For other inquiries, Embargoed For Release: 8:30 a.m. ET, April 20, 2015 To interview Philip Rosenberg, contact the NCI press office at orFor a photo of Rosenberg, click here. For other inquiries,](https://www.pdfsearch.io/img/7794577dd1261e2565215d432d3e089c.jpg) | Add to Reading ListSource URL: mb.cision.comLanguage: English - Date: 2015-04-14 08:53:38
|
---|
30![BMC Medical Genomics BioMed Central Open Access BMC Medical Genomics BioMed Central Open Access](https://www.pdfsearch.io/img/0c2c68de1b07b14636ba1307c618adf7.jpg) | Add to Reading ListSource URL: www.biomedcentral.comLanguage: English |
---|